Effects of Photo-Biomodulation in Stargardt Disease

PURPOSE: Stargardt disease (STGD1) is the most common hereditary macular degeneration and currently no treatments have been approved to interrupt the progression of the disease. The aim of this study was to evaluate the efficacy of photo-biomodulation in patients with Stargardt disease 1 year after...

Descripción completa

Detalles Bibliográficos
Autores principales: Scalinci, Sergio Zaccaria, Valsecchi, Nicola, Pacella, Elena, Trovato Battagliola, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760100/
https://www.ncbi.nlm.nih.gov/pubmed/35046633
http://dx.doi.org/10.2147/OPTH.S344378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760100/
https://www.ncbi.nlm.nih.gov/pubmed/35046633
http://dx.doi.org/10.2147/OPTH.S344378

Ejemplares similares